期刊
CHINESE CHEMICAL LETTERS
卷 33, 期 7, 页码 3315-3324出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2022.03.054
关键词
Nanozyme; Radiation therapy; Radiosensitization; ROS; Hypoxia
资金
- National Key R&D Program of China [2020YFA0710700]
- Natural Science Foundation of Jiangsu Province [BK20211596]
- Natural Science Foundation of China [21906110, 22022609]
- China Postdoctoral Science Foundation [2019M651950, 2020T130458]
- Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions
Radiotherapy is an important treatment for malignant tumors, but tumor resistance and damage to healthy tissues limit its efficacy. Developing novel radioenhancers and radioprotectants is crucial for improving clinical radiotherapy. Nanozymes have shown great potential in radiation medicine due to their multi-enzyme activities and microenvironment-responsive feature. This review systematically illustrates the progress of nanozymes in potentiating radiotherapy and radiation protection, including promoting reactive oxygen species generation, relieving tumor hypoxia, and preventing radiation-induced damage.
While radiotherapy is a mainstay therapeutic modality for malignant tumor, the intrinsic tumor resistance to radiotherapy, as well as the concomitant radiation injury to adjacent healthy tissues, greatly limits the efficacy of cancer radiotherapy. As a result, the development of novel radioenhancers and radioprotectants is highly desired for clinical radiotherapy. In recent years, nanozymes have inspired ever-growing research interest because of their multi-enzyme activities and microenvironment-responsive feature. In view of the significant progress of nanozymes in radiation medicine, we, in this review, systematically illustrate the impressive progress of nanozymes for potentiating radiotherapy and radiation protection. First, the types of nanozymes used in tumor radiotherapy are briefly discussed. Subsequently, the main strategies of nanozymes to enhance the radiotherapy efficiency, including promoting the generation of reactive oxygen species (ROS), relieving hypoxia in tumor microenvironment and combining with other cancer therapeutic regimens, are summarized. Finally, the advances of typical nanozymes for preventing radiation-induced hematopoietic damage and gastrointestinal damage are highlighted. (C) 2022 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据